Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting by Linden, Ariel
Improving casual inference with a doubly robust estimator that combines propensity score 
stratification and weighting 
Ariel Linden, DrPH1,2 
 
1 President, Linden Consulting Group, LLC - Ann Arbor, MI alinden@lindenconsulting.org 
2 Research Scientist, Division of General Medicine, Medical School - University of Michigan, 
Ann Arbor, Michigan, USA 
Corresponding Author Information: 
Ariel Linden, DrPH 
Linden Consulting Group, LLC 
1301 North Bay Drive 
Ann Arbor, MI USA 48103 
Phone: (971) 409-3505 
Email: alinden@lindenconsulting.org 
 
Key Words: propensity score, stratification, marginal mean weighting through stratification, 
inverse probability of treatment weights, doubly robust, treatment effects, causal inference 
 
Running Header: doubly robust stratification with weighting 
 
Acknowledgement: I wish to thank Julia Adler-Milstein for reviewing the manuscript and 
providing many helpful comments. 
  
This article is protected by copyright. All rights reserved.
This is the author manuscript accepted for publication and has undergone full peer review but
has not been through the copyediting, typesetting, pagination and proofreading process, which
may lead to differences between this version and the Version of Record. Please cite this article
as doi: 10.1111/jep.12714
ABSTRACT 
Rationale, aims and objectives: When a randomized-controlled trial (RCT) is not feasible, health 
researchers typically use observational data and rely on statistical methods to adjust for 
confounding when estimating treatment effects. These methods generally fall into three 
categories: (1) estimators based on a model for the outcome using conventional regression 
adjustment; (2) weighted estimators based on the propensity score (i.e. a model for the treatment 
assignment); and (3) ‘doubly robust’ (DR) estimators that model both the outcome and 
propensity score within the same framework. In this paper, we introduce a new DR estimator that 
utilizes marginal mean weighting through stratification (MMWS) as the basis for weighted 
adjustment. This estimator may prove more accurate than treatment effect estimators because 
MMWS has been shown to be more accurate than other models when the propensity score is 
misspecified. We therefore compare the performance of this new estimator to other commonly 
used treatment effects estimators. 
Method: Monte Carlo simulation is used to compare the DR-MMWS estimator to regression 
adjustment, two weighted estimators based on the propensity score, and two other DR methods. 
To assess performance under varied conditions, we vary the level of misspecification of the 
propensity score model as well as misspecify the outcome model. 
Results: Overall, DR estimators generally outperform methods that model one or the other 
components (e.g. propensity score or outcome). The DR-MMWS estimator outperforms all other 
estimators when both the propensity score and outcome models are misspecified and performs 
equally as well as other DR estimators when only the propensity score is misspecified.  
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Conclusions: Health researchers should consider using DR-MMWS as the principal evaluation 
strategy in observational studies, as this estimator appears to outperform other estimators in its 
class.  
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1. INTRODUCTION 
When conducting a randomized-controlled trial (RCT) is not feasible, health researchers 
typically use observational data and rely on statistical methods to adjust for confounding when 
estimating treatment effects. Although conventional regression remains the most common 
adjustment approach, methods that explicitly model the treatment assignment -- such as those 
using instrumental variables [1,2] or based on the propensity score [3] -- are now used more 
widely. 
 The propensity score is defined as the probability of assignment to the treatment group 
conditional on observed characteristics [3]. Propensity scores are generally estimated via logistic 
regression, reducing each individual’s set of covariates into a single scalar. It has been 
demonstrated that, in large samples when treatment and control groups have similar distributions 
of the propensity score, the groups also usually have similar distributions of the underlying 
covariates used to create the propensity score. This implies that observed pre-intervention 
covariates can be considered independent of treatment assignment (as if they were randomized), 
and therefore will not bias treatment effect estimates [3]. 
 A popular propensity score-based adjustment approach uses weighted regression to 
estimate the average treatment effect of an intervention, where the weight is based on the 
conditional probability of an individual receiving his/her own treatment. More specifically, 
treated individuals receive a weight equal to the inverse of the estimated propensity score 
(1/propensity score), and non-treated individuals receive a weight equal to the inverse of 1 minus 
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the estimated propensity score (1/1-propensity score). This weighting scheme, called the “inverse 
probability of treatment weights” (IPTW) [4,5], adjusts for differences in pre-intervention 
characteristics between participants and non-participants. IPTW is a widely-used weighting 
method in health research for point-treatment, longitudinal, and survival studies [5,6,7,8,9], 
among others. 
 Despite its ubiquitous use, a major limitation of IPTW weighted regression is that it is 
highly sensitive to misspecification of the propensity score model [10]. A misspecified 
propensity score may result in the generation of extreme weights for some individuals, which in 
turn, may cause the standard errors of the treatment effect variable (in the outcome model) to 
underestimate the true difference between the weighted estimator and the population parameter it 
estimates [11,12]. Thus, investigators should place particular importance on correctly estimating 
the propensity score [13]. However, because this is not always possible, a class of methods has 
evolved in which both the propensity score and the IPT-weighted outcome are modelled 
simultaneously within the same framework, providing asymptotically unbiased estimates as long 
as either model (propensity score or outcomes) is correctly specified. These methods are called 
“doubly robust” (DR) because they provide two opportunities, instead of only one, to derive 
unbiased treatment effect estimates [14,15,16].  
 In this paper, we introduce a new DR estimator that is based on marginal mean weighting 
through stratification (MMWS) [17,18,19]. The approach is motivated by recent simulation 
studies that demonstrate an advantage of MMWS over IPTW in eliciting lower bias and mean 
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squared error in weighted regression models when the propensity score is misspecified [17,20], 
as well as in empirical data that found that the IPTW results were much more variable, and in 
many cases, did not agree with the other two methods applied to the data (the stratification 
approach, and hierarchical outcome regression) [21]. 
 Given that a DR estimator is generally more robust than its stand-alone components (an 
estimator based on a model for the propensity score, or a model of the outcome using 
conventional regression adjustment), we hypothesize that the advantage that MMWS has over 
IPTW in estimators based on a model for the propensity score will carry over into the DR 
framework, making this DR estimator more robust than those based on IPTW. To test this 
hypothesis, we use Monte Carlo simulation to investigate how the proposed DR-MMWS 
estimator compares to other existing weighted regression and DR models in reducing bias under 
various levels of misspecification of both the propensity score and outcome models. 
 This paper is organized as follows: Section 2 describes the DR-MMWS framework. 
Section 3 details the construction and results of the Monte Carlo simulation, and Section 4 
provides discussion and conclusions. 
2. A DESCRIPTION OF THE DOUBLY ROBUST MMWS FRAMEWORK 
Marginal mean weighting through stratification [17,18,19] combines elements of both propensity 
score stratification and IPTW. Stratification (also known as subclassification [22,23]) entails 
stratifying the analytic sample into quantiles of the propensity score, which reflects a coarser 
version of matching in which treated and non-treated individuals within each stratum are 
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expected to be comparable on pre-treatment characteristics. It has been shown that stratifying the 
propensity score into 5 quantiles can remove over 90% of the initial bias due to the covariates 
used to generate the propensity score [23]. Next, a weight is generated for each individual based 
on their stratum and treatment assignment. The marginal mean weights are computed using the 
following formula [17]: 
𝑛𝑠 × Pr (𝑍 = 𝑧) 
𝑛𝑧 = 𝑧,𝑠     
where 𝑛𝑠 is the total number of individuals in a given stratum 𝑠, Pr (𝑍 = 𝑧) is the estimated 
probability of assignment to treatment group 𝑧, that is, the proportion of those actually receiving 
treatment 𝑧 in the sample, and 𝑛𝑧 = 𝑧,𝑠 is the total number of individuals in stratum 𝑠 who were 
actually assigned to treatment 𝑧. Thus, the weight is proportional to the ratio of the number of 
individuals in a given strata to the number of individuals within that strata actually receiving the 
treatment. Taken together, the stratification reduces bias in the observed covariates used to create 
the propensity score, and the weighting standardizes each treatment group to the target 
population. The MMWS weights are then specified as sampling weights within the outcome 
regression model.  
 To implement the doubly robust MMWS (DR-MMWS) estimator, we follow the 
framework proposed by Wooldridge [24,25] which applies IPTW together with regression 
adjustment (IPTW-RA), but we replace IPTW with MMWS. The DR-MMWS is operationalized 
in a multi-step process. First, the propensity score model is estimated. Next, the sample is 
partitioned into strata of the propensity score (typically 5 quintiles are used, although an optimal 
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stratification algorithm could be employed to determine if a different number should be used 
[Linden forthcoming]). Next, MMWS weights are computed for each individual in the sample. 
Next, using the MMWS as sampling weights, separate outcome models are fitted by a weighted 
regression for each treatment group, and treatment-specific predicted outcomes for each 
individual are obtained using the estimated coefficients from this weighted regression. Finally, 
the means of the treatment-specific predicted outcomes are computed. The contrasts between 
these averages provide the point estimates of the average treatment effects, and a bootstrapping 
procedure [26] (which includes both the estimation of the propensity score and outcome models) 
is used to obtain valid standard errors. 
3. MONTE CARLO SIMULATION STUDY 
In this simulation study, we examine how well the DR-MMWS estimator compares to several 
other regression-based treatment effect estimators in reducing bias in treatment effects 
estimation. These models fall into three general categories; (1) estimators based on a model for 
the outcome variable using conventional regression adjustment (RA); (2) estimators based on a 
model for the treatment assignment, using IPTW [4,5,6] and MMWS [17,18,19]; and (3) doubly-
robust estimators that model both the treatment assignment and outcome variable within the 
same framework, using an augmented IPTW approach (A-IPTW)  [16,27], IPTW combined with 
RA (IPTW-RA) [24,25], and the DR-MMWS estimator. 
 Our simulation design is a modified version of that described by Hong [17]. The 
estimated propensity score is misspecified to varying degrees (four scenarios) and the outcome 
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model (which follows a nonlinear normal distribution) is either correctly or incorrectly specified 
(two scenarios). In each scenario, 10,000 replications are drawn from the data-generating process 
described below, and repeated for sample sizes of 500 and 2000. For each replication, the 
treatment effect estimate and standard error (SE) for each model is recorded. Bias (the difference 
between the simulated effect and the true effect of 1.0), and the root mean squared error (RMSE) 
- a measure that magnifies and severely penalizes large errors - is then calculated across all 
samples. Lower values for all measures indicate better bias reduction. 
3.1 Data generating process for the treatment model 
As in Hong [17] (Simulation II), the true propensity score assigns treatment according to a 
polynomial function of X:   
 Pr = α0 + α1X + α2X2,  
where X is drawn from a standard normal distribution with a mean of 0 and a standard deviation 
of 1 and α0, α1, and α2 are manipulated to induce varying degrees of non-linearity as follows: 
 Model 1: α0 = 1 α1 =.2, α2 = -.2 
 Model 2: α0 = 1 α1 =.6, α2 = -.2 
 Model 3: α0 = 1 α1 =.2, α2 = -.6 
 Model 4: α0 = 1 α1 =.6, α2 = -.6 
The treatment assignment indicator Z is a Bernoulli random variable with the parameter of its 
distribution equal to the inverse logit of the true propensity score. A misspecified propensity 
score, which excludes the quadratic term X2, is used in all simulation models. 
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3.2 Data generating process for the outcome model 
As in Hong [17], a nonlinear model for potential outcomes was generated for each set of 
simulations. The model generated two potential outcomes Y(1) and Y(0) corresponding to the 
experimental condition Z = 1 and the control condition Z = 0. Both Y(1) and Y(0) are polynomial 
functions of a standard normal covariate X: 
 Y(1) = 6 + 0.5X + 0.25X2 - 0.125X3 + ϵ(1); 
 Y(0) = 5 + 0.5X + 0.25X2 - 0.125X3 + ϵ(0); 
 ϵ(1), ϵ(0) ~ N(0,0.25). 
The misspecified outcome model excludes the polynomial functions X2 and X3. In all models, the 
true treatment effect = 1. 
3.3 Model estimation 
In this section, we describe the estimation and inference procedures for each model and 
repetition over the simulation scenarios. All simulations and analyses reported in this paper were 
conducted using Stata version 14.2 (StataCorp., College Station, TX). 
 For each scenario, six different models were used to estimate the potential outcome mean 
for each of the three treatment levels. (1) Regression adjustment was implemented by regressing 
the outcome Y on all covariates (correctly specified model) or by regressing Y on X (misspecified 
model). (2) IPTW estimates were derived by, first, computing the IPTW weights as described 
earlier, and then specifying the weights as sampling weights (pweights) in the outcome model 
where the outcome Y was regressed on an indicator variable representing the two treatment levels 
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of Z. (3) MMWS estimates were derived by, first, dividing the sample equally into six strata 
based on the estimated propensity score (in keeping with Hong [17]), then by computing the 
MMWS weights by implementing a user-written command for Stata MMWS [28], and finally by 
regressing the outcome y on an indicator variable representing the treatment levels of Z, with the 
MMWS weights used as sample weights. (4) The A-IPTW estimator was implemented using the 
teffects aipw command. (5) The IPTW-RA estimator was implemented using the 
teffects ipwra command. (6) The DR-MMWS estimator was implemented as described in 
Section 2. All analyses were conducted with observations restricted to be within the region of 
common support (i.e. all individuals have a corresponding counterfactual). 
3.4 Monte Carlo simulation results 
Table 1 presents the simulation results for sample sizes of 500 and 2000, when the outcome 
model is correctly specified. As expected with a correctly specified outcome model, the RA 
estimator had zero bias and low RMSE. Of the two estimators based on a model for the treatment 
assignment (IPTW and MMWS), MMWS consistently produces substantially lower bias and 
RMSE than IPTW, and that par increases as the amount of non-linearity in the propensity score 
increases. All three DR models (IPTW-RA, A-IPTW, and DR-MMWS) perform best and 
produce unbiased estimates. 
 Table 2 presents the simulation results for sample sizes of 500 and 2000, when the 
outcome model is misspecified. The RA estimate is now biased due to the misspecification.  The 
values for IPTW and MMWS are identical to those in Table 1 because these estimators are 
This article is protected by copyright. All rights reserved.
unaffected by misspecification of the outcome model. IPTW-RA outperformed A-IPTW, 
deriving estimates very close to those of IPTW, while A-IPTW appears to obtain results that split 
the difference between RA and IPTW. DR-MMWS outperformed all the other estimators (save 
for MMWS) eliciting bias and RMSE estimates that are roughly half that of the other two DR 
estimators and RA.  
4. DISCUSSION 
In this paper we used Monte Carlo simulations to compare the performance of the DR-MMWS 
estimator to several other adjustment techniques commonly-used for estimating treatment effects 
in non-randomized studies. Our overall simulation results can be briefly summarized as follows: 
(1) When the outcome model is correctly specified but the propensity score model is 
misspecified, RA and all DR estimators provide unbiased estimates, while methods based solely 
on modeling the propensity score (i.e. MMWS and IPTW) provide biased estimates. That said, 
MMWS provides substantially less biased estimates than IPTW. (2) When both the propensity 
score and outcome models are misspecified, MMWS and DR-MMWS substantially outperform 
all other estimators.  
 In these simulations, the advantage DR-MMWS holds over these other estimators -- 
when both treatment and outcomes models are misspecified -- is due to the better performance of 
MMWS over IPTW when the propensity score is misspecified. That is, the DR-MMWS 
estimator is much more influenced by the propensity score model (and thus MMWS) than RA. 
Similarly, IPTW-RA is much more influenced by the propensity score model (and thus IPTW) 
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than RA. On the other hand, the A-IPTW framework appears to split the difference between the 
results of the IPTW and RA models.  
 Why does the MMWS outperform IPTW when the propensity score model is 
misspecified? Hong [17] suggests that given IPTW is computed as a direct function of the 
estimated propensity score, when the estimated propensity score is misspecified, the IPTW will 
systematically deviate from the true weight (leading to bias in the treatment effect estimates). 
Conversely, misspecification of the propensity score does not change propensity score stratum 
membership for units in either treatment group. Given that MMWS weights are estimated as a 
ratio of the sample sizes within each stratum, the computed weights will remain consistent even 
under misspecification, and therefore estimated treatment effects will remain robust. 
 Other empirical studies examining a similar array of adjustment methods have shown that 
doubly robust methods provide unbiased estimates when either the propensity score or outcomes 
model is misspecified [16,27,29,30,31,32]. However there currently appears to be no consensus 
as to which estimator is most appropriate if both models are misspecified [30,31,33]. Thus, from 
a practical stand-point, investigators may be best served by analyzing their data -- as we have 
here -- using DR-MMWS along with other estimators as a sensitivity analysis [34]. If all 
methods obtain similar treatment effect estimates, investigators will have greater confidence that 
the study results are unbiased. If, on the other hand, estimates differ substantially, a close 
examination of the results may clarify whether the inconsistencies are found between treatment 
model estimators based on the MMWS versus those using IPTW. If this appears to be where the 
This article is protected by copyright. All rights reserved.
discrepancy occurs, then investigators may either assume that the estimates of the DR-MMWS 
are more accurate (i.e. less biased) than those derived from estimators using IPTW, or they 
should consider re-estimating the propensity score, perhaps using machine learning techniques, 
which have been shown to outperform logistic regression in estimating the propensity score (i.e. 
predicting treatment assignment) [35,36,37,38,39,40]. 
 The primary limitation of this simulation study is that the performance of the various 
estimators on treatment effects was considered in the context of a specific data generating 
process. Second, our simulation assumed strong ignorability, though observational data in health 
research are typically laden with confounding from unobservables such as unmeasured 
motivation to change health behaviors [41,42]. Thus, future research should compare the 
performance of the DR-MMWS estimator to other methods in the context of more diverse data 
generating processes (including additional variable types and distributions) and violations to 
assumptions of the causal model. Finally, while simulation is, in and of itself, a form of cross-
validation, future comparisons using empirical data should be coupled with cross-validation 
techniques (i.e. k-fold or leave-one-out cross-validation) [43] to assess if DR-MMWS 
generalizes better than other estimators to individuals outside of the original estimation sample 
[44]. 
 In summary, the results of our simulation study suggest that the DR-MMWS estimator 
outperforms other regression-based treatment effect estimators when both the propensity score 
and outcome models are misspecified, and perform equally as well as other DR estimators when 
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only the propensity score is misspecified. Health researchers should consider using DR-MMWS 
as the principal evaluation strategy in observational studies, as it is unlikely that he or she will 
know which of the two models (or both) is misspecified.  
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Table 1: Monte Carlo results for estimators when the outcome is correctly specified, and the propensity score is misspecified to varying degrees. 
 
  Propensity score parameters N = 500 N = 2000 
  α0  α1  α2  Bias SE RMSE Bias SE RMSE 
RA 1 0.2 -0.2 0.00 0.02 0.02 0.00 0.01 0.01 
 1 0.6 -0.2 0.00 0.03 0.03 0.00 0.01 0.01 
 1 0.2 -0.6 0.00 0.02 0.02 0.00 0.01 0.01 
  1 0.6 -0.6 0.00 0.02 0.02 0.00 0.01 0.01 
IPTW 1 0.2 -0.2 -0.07 0.04 0.08 -0.08 0.02 0.09 
 1 0.6 -0.2 -0.07 0.05 0.09 -0.08 0.02 0.08 
 1 0.2 -0.6 -0.13 0.04 0.14 -0.16 0.02 0.16 
  1 0.6 -0.6 -0.13 0.04 0.13 -0.15 0.02 0.15 
MMWS 1 0.2 -0.2 -0.02 0.03 0.04 -0.03 0.02 0.04 
 1 0.6 -0.2 -0.02 0.03 0.04 -0.03 0.02 0.04 
 1 0.2 -0.6 -0.03 0.03 0.04 -0.05 0.02 0.05 
  1 0.6 -0.6 -0.02 0.03 0.03 -0.04 0.02 0.04 
IPTW-RA 1 0.2 -0.2 0.00 0.02 0.02 0.00 0.01 0.01 
 1 0.6 -0.2 0.00 0.03 0.03 0.00 0.01 0.01 
 1 0.2 -0.6 0.00 0.03 0.03 0.00 0.01 0.01 
  1 0.6 -0.6 0.00 0.03 0.03 0.00 0.01 0.01 
A-IPTW 1 0.2 -0.2 0.00 0.02 0.02 0.00 0.01 0.01 
 1 0.6 -0.2 0.00 0.03 0.03 0.00 0.01 0.01 
 1 0.2 -0.6 0.00 0.03 0.03 0.00 0.01 0.01 
  1 0.6 -0.6 0.00 0.03 0.03 0.00 0.01 0.01 
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DR-MMWS 1 0.2 -0.2 0.00 0.03 0.03 0.00 0.01 0.01 
 1 0.6 -0.2 0.00 0.03 0.03 0.00 0.01 0.01 
 1 0.2 -0.6 0.00 0.03 0.03 0.00 0.01 0.01 
  1 0.6 -0.6 0.00 0.03 0.03 0.00 0.01 0.01 
Note: RA = regression adjustment; IPTW = inverse probability of treatment weights; MMWS = marginal mean weighting through stratification; IPTW-RA = 
inverse probability of treatment-weighted regression adjustment; A-IPTW = augmented inverse probability of treatment weighting; DR-MMWS = doubly robust 
marginal mean weighting through stratification; SE = standard error; RMSE = root mean squared error. 
  Table 2: Monte Carlo results for estimators when the outcome is misspecified, and the propensity score is misspecified to varying degrees. 
 
  Propensity score parameters N = 500 N = 2000 
  α0  α1  α2  Bias SE RMSE Bias SE RMSE 
RA 1 0.2 -0.2 -0.11 0.06 0.12 -0.11 0.03 0.11 
 1 0.6 -0.2 -0.10 0.05 0.12 -0.11 0.02 0.11 
 1 0.2 -0.6 -0.22 0.05 0.22 -0.22 0.02 0.22 
  1 0.6 -0.6 -0.18 0.04 0.18 -0.18 0.02 0.18 
IPTW 1 0.2 -0.2 -0.07 0.04 0.08 -0.08 0.02 0.09 
 1 0.6 -0.2 -0.07 0.05 0.09 -0.08 0.02 0.08 
 1 0.2 -0.6 -0.13 0.04 0.14 -0.16 0.02 0.16 
  1 0.6 -0.6 -0.13 0.04 0.13 -0.15 0.02 0.15 
MMWS 1 0.2 -0.2 -0.02 0.03 0.04 -0.03 0.02 0.04 
 1 0.6 -0.2 -0.02 0.03 0.04 -0.03 0.02 0.04 
 1 0.2 -0.6 -0.03 0.03 0.04 -0.05 0.02 0.05 
  1 0.6 -0.6 -0.02 0.03 0.03 -0.04 0.02 0.04 
IPTW-RA 1 0.2 -0.2 -0.06 0.05 0.08 -0.08 0.03 0.08 
 1 0.6 -0.2 -0.04 0.04 0.06 -0.06 0.02 0.07 
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 1 0.2 -0.6 -0.12 0.04 0.13 -0.16 0.03 0.16 
  1 0.6 -0.6 -0.10 0.04 0.11 -0.13 0.03 0.13 
A-IPTW 1 0.2 -0.2 -0.10 0.06 0.12 -0.10 0.03 0.11 
 1 0.6 -0.2 -0.12 0.07 0.14 -0.12 0.03 0.12 
 1 0.2 -0.6 -0.23 0.05 0.23 -0.22 0.03 0.23 
  1 0.6 -0.6 -0.23 0.06 0.24 -0.23 0.03 0.23 
DR-MMWS 1 0.2 -0.2 -0.02 0.04 0.04 -0.04 0.02 0.04 
 1 0.6 -0.2 -0.02 0.03 0.04 -0.04 0.02 0.04 
 1 0.2 -0.6 -0.03 0.03 0.04 -0.05 0.02 0.05 
  1 0.6 -0.6 -0.02 0.03 0.04 -0.04 0.02 0.04 
Note: RA = regression adjustment; IPTW = inverse probability of treatment weights; MMWS = marginal mean weighting through stratification; IPTW-RA = 
inverse probability of treatment-weighted regression adjustment; A-IPTW = augmented inverse probability of treatment weighting; DR-MMWS = doubly robust 
marginal mean weighting through stratification; SE = standard error; RMSE = root mean squared error. 
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